New Local Clinical Trial Recruiting Now!

Written By Victoria Rogan

In exciting news for both the Australian & New Zealand FA communities, Design Therapeutics are enroling for local clinical trials for their DT-216P2 medication. This important study is currently taking place in Melbourne & Sydney.

Please read the Design Therapeutics communication below regarding the trial and enrolment.

Victoria Rogan
Next

omav Early Access Program Not Impacted by PBAC Decision